Real-time enrollment status for this autoimmune lymphoproliferative syndrome clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 9:22 PM UTC
| NCT Number | NCT06730126 |
| Recruiting Status | Recruiting |
| Condition | Autoimmune Lymphoproliferative Syndrome |
| Phase | PHASE2 |
| Target Enrollment | 15 participants |
| Active Locations | 3 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | June 11, 2026 (Jun 11, 2026) |
As of July 20, 2026: Clinical trial NCT06730126 is currently recruiting participants. This phase2 study for autoimmune lymphoproliferative syndrome is actively seeking new participants at 3 locations across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06730126 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06730126 was last updated Jun 11, 2026 (June 11, 2026). HelloStudys verifies this status automatically.